Introducing MIPP: The Modelling, ImmunoProfiling and Pharmacology Platform for Translational Innovation

We hope to see many of you at this event!

Don't miss the next Ecosystem Breakfast on the topic: Introducing MIPP: The Modelling, ImmunoProfiling and Pharmacology Platform for Translational Innovation 

With: Anna Martirosyan, MIPP platform (Modelling, ImmunoProfiling and Pharmacology Platform), Hôpitaux Universitaires de Marseille

Dr. Anna Martirosyan is the Director of Business Development and Partnerships within the MIPP platform (Modelling, ImmunoProfiling and Pharmacology Platform), where she designs and implements scientific and industrial collaboration strategies aimed at accelerating therapeutic innovation in immuno-oncology and precision medicine.

She has over 12 years of expertise at the interface of translational immunology, technology development, and healthcare innovation strategy. Her work focuses on building collaborative ecosystems connecting academic research, the biopharmaceutical industry, and clinical development, with a strong emphasis on translating scientific discoveries into patient-impacting therapeutic and diagnostic solutions.

Prior to joining MIPP, she served as Head of the Scientific Department within an international NGO dedicated to healthcare innovation, where she led international public–private partnerships and contributed to the creation of a translational research laboratory in immuno-oncology. She also helped structure funding strategies and collaborative innovation initiatives in medical biotechnology.

She previously worked for 6 years at Veracyte, an international company specializing in molecular diagnostics in immuno-oncology, where she was the Team Leader of scientific experts within the biopharma department. There, she developed strong expertise in strategic business development, management of industrial partnership portfolios, and leadership of complex scientific projects in regulated and industrial environments.

Dr. Martirosyan holds a PhD in immunology from the Centre d’Immunologie de Marseille-Luminy. Her career is dedicated to developing integrated scientific and industrial innovation models that facilitate the rapid translation of research advances into clinical practice and next-generation biopharmaceutical solutions.